Women's health, prevention, elderly lady, patient, doctor, methylation marker test QIAsure, 04/2016, (Person/s, Photography, MDx, Women’s health (WH), Doctor/Physician, Patient, Doctors office, Portrait)
Syndromic Testing

Supporting improved healthcare

Multiplex PCR syndromic testing with QIAstat-Dx has the potential to revolutionize infectious disease diagnostics. These tests can deliver results for several pathogens in about an hour and require just a single patient sample. QIAstat-Dx syndromic testing is helping infectious disease experts supply better care to their patients across the globe.

Getting results faster – and seeing patients thrive

Watch the video to hear Jean-François Timsit, head of the intensive care unit at Bichat Hospital in Paris, and Florence Morfin, professor of virology at the Hospices Civils de Lyon, reflect on how rapid molecular testing has helped their patients get back on their feet.

“You have to test everything if you want to find everything”

Watch the video to hear why Dr. Benoit Visseaux from Bichat-Claude Bernard Hospital says a more flexible and comprehensive solution for multiplex PCR testing is needed.

Célestin Alexis Agbessi, MD, PhD, Emergency Department,

Preserve antibiotics and save on costs

“In one hour we can introduce the treatment … it will change our habits in prescriptions, saving money, saving on antibiotics and treatment side effects”

Célestin Alexis Agbessi, MD, PhD, Emergency Department, Bichat-Claude Bernard Hospital, France

Prof. Dr. med. Stephan Gehring, Department of Pediatrics, Children’s Hospital of Mainz, Germany
Replace out-dated microbiology methods

“Only an accessible, fast, sensitive and broad diagnostic tool provides the opportunity to influence therapeutic decisions. Rapid diagnostic systems for the detection of pathogens are very promising tools, as the results can influence therapy decisions and infection control in a short period of time. We’ve found it can replace conventional microbiology in many cases.”

Prof. Dr. med. Stephan Gehring, Department of Pediatrics, Children’s Hospital of Mainz, Germany

Dr. Iolanda Jordan Garcia, MD, PhD PICU Senior Staff, SJD Barcelona Children’s Hospital, Spain
Increase diagnostic accuracy and yield
We’ve found the QIAstat-Dx [respiratory panel] easy to work with and it provides quick results. The QIAstat-Dx panel can support a comprehensive, evidence-based diagnosis, which is particularly important for our patients. Compared to traditional microbiology methods, syndromic testing has allowed us to achieve a better diagnostic yield and diagnostic accuracy.”

Dr. Iolanda Jordan Garcia, MD, PhD PICU Senior Staff, SJD Barcelona Children’s Hospital, Spain

Dr. Justin Chai K.L., MD, OHD, BCMAS, Head of Emergency Department, Gleneagles Hospital Kota Kinabalu, Malaysia
Get urgent results for acutely ill patients

“The QIAstat-Dx panels have been proven to be useful and crucial for emergency doctors to make an accurate diagnosis for patients presenting to the emergency department. The results give us a better understanding of the patient’s course of disease and enable us to formulate the best treatment plans for our patients.”

Dr. Justin Chai K.L., MD, OHD, BCMAS, Head of Emergency Department, Gleneagles Hospital Kota Kinabalu, Malaysia

Pierre Lureau, PhD, Medical Director, Medical Biology Laboratory, Hospital Center of Niort, France
Perform tests quickly and easily

“We have chosen QIAstat-Dx because we can access the Ct [values] and the amplification curves. It was mandatory for me to have access to Ct values and amplification curves… It's a one-step quick preparation of the sample. It’s easy to learn and then be used 24 hours a day.”

Pierre Lureau, PhD, Medical Director, Medical Biology Laboratory, Hospital Center of Niort, France

Dr. Liliana Gabrielli, MD, Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy
Easily access Ct values

“An advantage of the QIAstat-Dx is the availability of Ct [values]. When we have a positive result for a virus, we need to perform the viral load but we need time. We need 4, 5, 6 hours. In these cases, it’s important to have an indication of the Ct. And now clinicians, after SARS-CoV-2, understand very well what the Ct is. For coronavirus, they often ask what is the Ct? The indication of the Ct is very, very important. ” 

Dr. Liliana Gabrielli, MD, Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy

Thomas Sundelin, PhD, Clinical Microbiology Department, Herlev Hospital, Denmark
Get more than a yes or no answer

“We do have questions from clinicians from time to time when the pathogen detected is a surprise. It’s nice to have as much information as possible regarding the sample, especially in those cases where it’s a surprise finding. With QIAstat-Dx, now we can actually give them additional information.”

Thomas Sundelin, PhD, Clinical Microbiology Department, Herlev Hospital, Denmark

The QIAstat-Dx Analyzer and QIAstat-Dx panels are intended for in vitro diagnostic use.  

Product availability may differ from country to country based on regulations and approvals. Contact your country representative for further details. 

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor).